Objective: To compare the relationships between markers of total and regional adiposity with muscle fat infiltration in type 1 diabetic and type 2 diabetic subjects and their respective nondiabetic controls, and to document these relationships in type 1 diabetic subjects. Design: Cross-sectional study. Subjects: In total, 86 healthy, with type 1 diabetes, type 2 diabetes or control subjects. Each diabetic group was matched for age, sex and body mass index with its respective nondiabetic control group. Measurements: Measures of body composition (hydrodensitometry), fat distribution (waist circumference, abdominal and mid-thigh computed tomography scans) and blood lipid profiles were assessed. Results: Low attenuation mid-thigh muscle surface correlated similarly with markers of adiposity and body composition in all groups, regardless of diabetes status, except for visceral adipose tissue and waist circumference. Indeed, relationships between visceral adiposity and muscle adiposity were significantly stronger in type 2 vs type 1 diabetic subjects (Po0.05 for comparison of slopes). In addition, in well-controlled type 1 diabetic subjects (mean HbA 1c of 6.8%), daily insulin requirements tended to correlate with low attenuation mid-thigh muscle surface, a specific component of fat-rich muscle (r ¼ 0.36, P ¼ 0.08), but not with glycemic control (HbA 1c ). Conclusion: This study suggests that the relationship of central adiposity and muscle adiposity is modulated by diabetes status and is stronger in the insulin resistant diabetes type (type 2 diabetes). In well-controlled nonobese type 1 diabetic subjects, the relationship between muscle fat accumulation and insulin sensitivity was also maintained.
Introduction
Excess body fat leads to increasing insulin resistance which predisposes to type 2 diabetes. 1 Insulin resistance in obesity and type 2 diabetes is further strongly associated with regional adiposity, most notably with the excess accumulation of abdominal or visceral adipose tissue (VAT) 2 and with an accumulation of lipids in muscle. 3 In addition, VAT is an important predictor of insulin resistance in nondiabetic men with both normal and increased adiposity. 4 Computed tomography (CT) has the potential to distinguish different tissue types in vivo on the basis of their attenuation characteristics, which, in turn, are a function of tissue density and chemical composition. 5 Computed tomography imaging has been used to reveal alterations in the attenuation values of muscle as a marker of higher lipid within muscle related to insulin resistance in obesity and type 2 diabetes. 6 This was also shown to be strongly associated with insulin resistance independently of VAT.
Hyperglycemia per se, in either the fasting state or following glucose load, results from insulin resistance. However, in vivo studies performed in type 1 diabetic patients 8 and rats 9 demonstrated that chronic hyperglycemia is an independent factor in the development of insulin resistance, a phenomenon referred to as glucose toxicity. 10 Thus, the presence of insulin resistance and concurrent hyperglycemia in type 2 diabetes makes it difficult to distinguish their etiology. To our knowledge, only two studies have examined the relationships between insulin sensitivity and muscle lipid content in type 1 diabetes and have presented conflicting results. 11, 12 Perseghin et al. 11 showed a positive association between intramyocellular lipid content (IMCL) and insulin resistance suggesting that accretion of lipids within skeletal muscle is a marker of insulin resistance in type 1 diabetes, while Ebeling et al. 12 did not shown this relationship. This discrepancy may be explained by the method of assessment of the muscle lipids (magnetic resonance spectroscopy vs biopsy) and/or by the degree of glycemic control (HbA 1c values of 8.6 vs 7.7%). However, the subjects in both studies presented suboptimal glycemic control so that chronic hyperglycemia may have confounded these relationships. To our knowledge, skeletal muscle attenuation, measured by noninvasive methods such as CT, has not been studied in relation to adiposity (total and regional) and metabolic profile in well-controlled type 1 diabetic subjects (mean HbA 1c o7%), where chronic hyperglycemia is minimized. As hyperglycemia can by itself cause insulin resistance, the effect of insulin resistance on the relationship between muscle fat infiltration and overall adiposity remains unclear in the diabetic state. In this regard, type 1 diabetic subjects with good glycemic control are relatively insulin sensitive, and thus constitute a good comparison group for subjects with type 2 diabetes, which are almost all insulin resistant. Therefore, the aims of this study were: (1) to examine the relationships between markers of whole-body and regional adiposity and muscle fat infiltration and their modulation by diabetic status, and (2) to document these relationships in well-controlled subjects with type 1 diabetes.
Materials and methods

Subjects
A total of 86 healthy men (n ¼ 54) and women (n ¼ 32) participated in the study. The group included subjects with type 2 diabetes (n ¼ 18), with type 1 diabetes (n ¼ 25) and their respective nondiabetic controls matched for age, sex and body mass index (BMI). Some type 2 diabetic subjects were on medication: five were treated with oral hypoglycemic agents (glyburide and/or glucophage) and one with insulin (Humulin N, Humulin R and glucophage). The others were either treated with diet alone (n ¼ 5) or were newly diagnosed diabetic subjects. All type 1 diabetic subjects were on a basal-bolus insulin regimen using insulin Humalog s before every meal and Humulin N s before breakfast and at bedtime. This study was approved by the Medical Ethics Committee of Laval University, and all subjects gave their informed written consent.
Diabetes status
Type 1 diabetic subjects were included if they had a medical history of absolute need for insulin and low c-peptide. In this study, the mean insulin dose was 60.6719.6 (range 26-104) units/day and the median of fasting c-peptide was 29 (range 0-142) pmol/l. The median of c-peptide in type 2 diabetes was 1306 (range 656-2177) pmol/l. Type 2 diabetic subjects were included if they had a 2-h plasma glucose X11.1 mmol/l during an OGTT or a fasting plasma glucose X7.0 mmol/l. 13 In the control group for type 1 diabetes, one subject had a 2-h postglucose value of 8.1 mmol/l during the OGTT, which characterizes him as having impaired glucose tolerance. Analysis with or without this subject did not change the findings of the study. All other control subjects had normal glucose tolerance (2-h postglucose value o7.8 mmol/l). Insulin sensitivity was estimated from fasting glucose and insulin values using HOMA-IR. 14 Anthropometry, body composition and metabolic profile Subjects arrived at the laboratory at 0800 hours after fasting for 10 h. Type 1 diabetic subjects omitted their morning insulin doses and type 2 diabetic subjects on antidiabetic medications omitted them for 12 h. Subjects were advised not to exercise strenuously for 24 h before the study. A medical history was obtained from all subjects.
Body mass index (kg/m 2 ) was calculated using weight measured to the nearest 0.1 kg with the subject wearing a bathing suit and height measured to the nearest centimeter using a standard beam scale with the subject barefoot. Waist circumference (WC) was measured as specified at the Airlie Consensus Conference. 15 The closed-circuit helium dilution method 16 was used to assess residual lung volume. Body density was determined by hydrodensitometry, 17 and the Siri formula 18 was used to estimate the percentage body fat from body density. Fat mass (FM) was calculated from the derived percentage body fat and total body weight. Fat-free mass (FFM) was calculated by subtracting FM from body weight.
Computed tomography (HiSpeed CT/i scanner, General Electric, Milwaukee, WI, USA) was used to measure the crosssectional area of abdominal total adipose tissue (TAT), VAT and subcutaneous adipose tissue (SAT), muscle and midthigh bone, and to characterize muscle attenuation using an established method. 19 Briefly, a 10-mm thick cross-sectional scan was obtained, centered at the L4-L5 vertebral disc space using 100 mA with a scanning time of 3 s and a 512 Â 512
Muscle adiposity in type 1 and type 2 diabetes MC Dubé et al matrix. 20 Adipose tissue (AT) areas were determined using commercially available software (GE Medical Systems version 5.0, Milwaukee, WI, USA) and VAT and SAT boundaries were defined using a manual cursor. As an index of the relative distribution of abdominal AT, the ratio of VAT/TAT surface was calculated. With the subject supine, a 10-mm thick cross-sectional scan of both legs was also obtained at the mid-point between the anterior iliac crest and the patella. Areas of bone, AT, and skeletal muscle were measured by selecting the following attenuation values: X200 Hounsfield units (HU) for bone, À190 to À30 HU for AT, and 0-100 HU for muscle; mean muscle attenuation was determined from all pixels within this range. 7 Total thigh AT (À190 to À30 HU) was subdivided into two compartments of AT present above the fascia lata (subcutaneous thigh fat) and below the fascia lata (deep thigh fat). As an index of the relative distribution of mid-thigh AT, the ratio of deep/total AT surface was calculated. The surface of muscle with low attenuation (0-34 HU) represents the specific component of fat-rich muscle. Muscle with attenuation measures above these values (35-100 HU) is considered as having a normal fat content. Whole-muscle surface and attenuation are calculated using the entire range of attenuation (0-100 HU). These methods of thigh composition analyses using CT have been previously described. 21 As an index of the proportion of muscle having a fat-rich phenotype, the ratio of low attenuation muscle surface/total muscle surface area was calculated. Blood lipids were measured from blood samples collected at 0800 hours after a 10 h fast. Total cholesterol and triglycerides (TG) concentrations were determined enzymatically with the use of commercial kits, as described elsewhere. 22 High-density lipoprotein (HDL)-cholesterol and low-density lipoprotein (LDL)-cholesterol concentrations were analyzed after precipitation of LDL in the infranatant fluid with heparin and magnesium chloride. 23 
Statistical analyses
The data are presented as means (7s.d.). When not normally distributed, group differences were assessed on logtransformed values. Type 1 diabetes, type 2 diabetes and their respective controls were compared by analysis of variance. Partial correlations, corrected for age and sex, were computed. Analysis of covariance (ANCOVA) were performed to examine differences among groups and potential interactions. Following adjustment for age and sex, comparison of slopes 24 were used to examine the linear regressions of muscle phenotypes to body composition indices across groups of subjects. Differences in slopes were considered statistically significant with Po0.05. Stepwise multiple regression analysis was performed to determine which body composition variable best predicted muscle fat infiltration. All statistical analyses were performed with JMP Software version 4 for Macintosh and the SAS statistical package version 8.02 (SAS Institute Inc., Cary, NC, USA).
Results
Subject characteristics
Subject characteristics are shown in Mid-thigh adipose tissue and muscle composition Type 2 diabetic subjects had greater cross-sectional areas of total and subcutaneous thigh fat than type 1 diabetic subjects (Po0.01, Table 1 ). Deep thigh fat was significantly higher in type 1 diabetic subjects compared to their nondiabetic controls and similar to type 2 diabetic subjects and their controls. The ratio of mid-thigh deep fat/total fat was higher in type 1 diabetes compared to their controls and compared to type 2 diabetes (Po0.01, Table 1 ). Moreover, for all subjects combined, there was a correlation between the ratio of VAT/TAT surface and the ratio of mid-thigh deep fat/ total fat (r ¼ 0.43, Po0.0001). The surface area of muscle with normal attenuation was greater whereas the surface of muscle with a low attenuation was lower in type 1 compared to type 2 diabetic subjects (Table 1, Po0.01); this is reflected by the lower ratio of low attenuation muscle surface/total muscle surface in type 1 diabetic subjects. Whole-muscle attenuation was greater in type 1 compared to type 2 diabetic subjects, a difference that was also observed between type 1 controls and type 2 control subjects (Po0.01).
Correlation between muscle fat indices and body composition
Correlations between indices of muscle fat infiltration and body composition, corrected for age and sex, are shown in Table 2 . Whole-muscle attenuation was negatively associated with FM, WC, VAT and SAT (Po0.05). These significant correlations were present in all groups except for type 2 diabetes controls. Low attenuation muscle surface was strongly correlated with body composition indices in type 1 diabetes, type 1 diabetes controls and type 2 diabetes subjects (range r ¼ 0.42-0.76, all Po0.05) but this was less marked in type 2 diabetes controls. Similar results were obtained for the ratio of low attenuation muscle surface/total muscle surface (range r ¼ 0.49-0.76, all Po0.05).
For the relations between measures of adiposity and all three indices of muscle fat infiltration, differences in the slopes of these relationships between groups were seen only when considering visceral adiposity markers ( Figure 1 ). As shown for comparisons between subjects with type 1 and type 2 diabetes, there were significant differences in the slopes of the regression lines between VAT and whole-muscle attenuation (slopes À1.57 vs À8.11, Po0.05), low attenuation muscle surface (slopes 12.57 vs 46.83, Po0.005) or low attenuation muscle surface/total muscle surface (slopes 0.06 vs 0.29, Po0.001) as well as between type 2 diabetes and their controls (slopes À8.11 vs 1.36, Po0.01, 46.83 vs 9.41, Po0.005, 0.29 vs À0.03, Po0.0005, for all three indices, respectively). Indeed, despite significant partial correlations between these three muscle variables and VAT in all groups, stronger relationships were found in type 2 diabetic subjects. In addition, comparison of the slopes show that the correlation between WC and the ratio of low attenuation muscle surface/total muscle surface was significantly different between type 2 diabetic subjects and their controls.
Stepwise multiple regressions were performed to determine which indicators of body composition (BMI, FM, FFM, WC, VAT and SAT) best predicted muscle fat infiltration. Markers of visceral adiposity (WC, VAT) were found to be predictors of muscle adiposity phenotypes only in type 2 diabetes (partial r 2 from 0.29 to 0.54, Po0.05). Although other adiposity variables (FM, BMI) were retained in this model for other groups, the strength of their prediction was much lower (partial r 2 from 0.21 to 0.38, Po0.05). Analysis of covariance were performed to examine differences among groups and potential interactions. We found only one interaction between BMI and group (type 1 vs type 2 diabetes) in low attenuation muscle surface (Po0.01). This suggests that with a similar increase in BMI, low attenuation muscle surface (fat-rich muscle) increases more in type 2 compared to type 1 diabetic subjects.
Type 1 diabetes, muscle fat infiltration indices and insulin dose
In type 1 diabetic subjects, daily dosage of insulin was positively associated with general adiposity indices (weight, BMI, WC, r ¼ 0.39 to 0.54, all Po0.05). Moreover, there was a tendency for a correlation between insulin dose and low attenuation muscle surface, the specific component of fatrich muscle (r ¼ 0.36, P ¼ 0.08).
Discussion
Although relationships between markers of whole-body adiposity and muscle adiposity have previously been shown, the data presented here are, to our knowledge, the first to explore these relationships with regards to diabetic status, comparing subjects with type 1 and type 2 diabetes. In the present study, type 2 diabetic subjects were significantly more insulin resistant compared to their controls and type 1 diabetic subjects had standard insulin doses suggesting normal insulin sensitivity. However, we did not specifically measure insulin sensitivity in our subjects.
Diabetes status, central and muscle fat relations
Our results show stronger relationships between visceral adiposity and muscle adiposity in type 2 diabetes when compared to well-controlled type 1 diabetic subjects (mean HbA 1c of 6.8%). In fact, for all three measures of muscle fat infiltration, comparisons of slopes show that VAT was more strongly related to muscle fat in type 2 diabetes. This suggests that, in the presence of insulin resistance, for each increment in VAT, more fat is accumulated at the muscle level in type 2 diabetes than in type 1 diabetes. These data correspond to observations by Gan et al. 4 that VAT is a stronger predictor of insulin resistance than total adiposity in nondiabetic men with both normal and increased adiposity. The fact that type 1 diabetic patients are not different from their controls and from nondiabetic obese subjects suggests that the presence of insulin resistance in type 2 diabetic subjects may strongly modulate the relationship between muscle adipose characteristics and VAT in our population. Moreover, despite high correlations between mid-thigh adiposity indices and VAT in all groups, the strongest relationships were found in type 2 diabetes subjects. In addition, in type 2 diabetes, stepwise multiple regression showed that VAT was the best predictor of midthigh adiposity indices, whereas it was not in other groups. Finally, the interaction between BMI and diabetes type in low attenuation muscle surface suggests that with a similar increase in BMI, the component of fat-rich muscle increases more in type 2 diabetic subjects than in type 1. It is known that chronic hyperglycemia is involved in the development of insulin resistance. 10 The weaker relationship Muscle adiposity in type 1 and type 2 diabetes MC Dubé et al between abdominal and mid-thigh adiposity indices in subjects with type 1 diabetes compared to type 2 diabetes, suggests that hyperglycemia plays a more minor role in insulin resistance than muscle fat accumulation in those latter subjects. Indeed, current models of lipotoxicity focus on the impaired insulin signaling cascade related to the production of lipid-derived molecules such as fatty acyl-CoA, ceramides, diacylglycerols for which increased IMCL would serve as a surrogate marker. 26 Moreover, our type 1 diabetic subjects presented good metabolic control which minimized their hyperglycemia. They were also likely insulin sensitive as evidenced by their standard daily insulin requirement. Therefore, all these observations point to a stronger relationship between central and muscle adiposity in the presence of insulin resistance. In this study, and as it was expected, type 2 diabetic subjects had higher levels of adiposity compared to type 1 diabetic subjects. More specifically, when abdominal CT measurements were compared, higher TAT, VAT and SAT were found in type 2 diabetes. However, the ratio of VAT/TAT was similar between both diabetes types suggesting that the distribution of abdominal AT was similar in both groups. In addition, when CT measurements at mid-thigh were compared, type 2 diabetic subjects presented higher levels of mid-thigh total AT, but had similar levels of deep AT resulting in a smaller ratio of deep/total AT compared to type 1 diabetic subjects. Interestingly, this ratio was positively correlated with VAT/TAT suggesting that thigh fat distribution follows that of the abdomen. This is in agreement with other studies such as that of Sinha et al. 27 who found a significant association between extramyocellular and intramyocellular TG stores and visceral FM in obese adolescents.
Subjects with type 1 diabetes presented higher total muscle surface compared to type 2 diabetes. Although it is conceivable that the anabolic effects of chronic hyperinsulinemia related to their insulin treatment could account for this difference, this is unlikely since there was no difference between the total muscle surface in type 1 diabetes and their respective controls. Age may have influenced muscle characteristics. In effect, type 1 diabetic subjects and their controls were much younger compared to type 2 diabetic subjects. Fitness levels may also have played a role since type 1 diabetic subjects were younger and possibly more active than the type 2 diabetic group. Despite these differences, the relationship of VAT/TAT to mid-thigh deep/ total AT was maintained between all groups. Type 1 diabetes, body fat distribution, central and muscle fat relations Type 1 diabetic subjects presented deep thigh fat values similar to type 2 diabetic subjects and their controls but higher than their respective controls. This may reflect an increase in fat deposition in this area related to diabetes status or chronic hyperglycemia. However, deep thigh fat Figure 1 Relationships between visceral adipose tissue (VAT) surface (log) and residuals (both adjusted for age and sex) muscle phenotypes measured by computed tomography (CT)-scan in type 1 (gray triangles) and type 2 (black circles) diabetic subjects and: (a) whole-muscle attenuation; (b) low attenuation muscle surface; (c) low attenuation muscle surface/total muscle surface.
was not related to the metabolic parameters (glycemic control, diabetes duration and blood pressure) measured in our patients.
In type 1 diabetes, daily insulin requirement was significantly correlated with general adiposity markers and tended to correlate with the specific component of fat-rich muscle, suggesting that even in well-controlled type 1 diabetes, greater muscle fat accumulation might be related to higher daily insulin requirement, a surrogate for insulin resistance. Thus, type 1 diabetic subjects could suffer a similar deterioration of insulin sensitivity with increased muscle fat accumulation as it is seen in type 2 diabetes. However, stronger conclusions on this point will require precise measurements of insulin sensitivity.
Elevated muscle TG levels have been reported for type 1 diabetic subjects after the withdrawal of insulin for 24 h. 28 In 47.6%) metabolic control and found that those with better metabolic control showed a higher insulin-stimulated metabolic clearance rate in association with lower IMCL content. In the Ebeling et al. 12 study, where subjects had better metabolic control (mean HbA 1c of 7.7%), no relation between muscle fat and insulin resistance was found. In the present study, no relationship was found between muscle lipids, estimated by CT scan, and HbA 1c . The glycemic control in our type 1 diabetic subjects was excellent (mean HbA 1c of 6.8%), reflecting decreased chronic hyperglycemia. Thus, minimizing hyperglycemia by achieving recommended glycemic control might help to normalize the potential muscle fat abnormalities observed in type 1 diabetic subjects. However, the results from the present study and those of Ebeling et al. 12 and Perseghin et al.
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might also reflect the different methods used for the assessment of intramuscular lipid. In subjects from the same cohort used in the present study, a significant negative relationship between measurements of intracellular muscle fat infiltration (Oil Red O staining) and muscle attenuation is observed (r ¼ À0.46, Po0.05) (data not shown). This suggests that muscle attenuation could serve as an indicator of fat accretion within myocytes. In summary, CT whole-muscle attenuation values of skeletal muscle are lower in type 2 compared to type 1 diabetes and negatively associated with local and general adiposity. Although the relationships between markers of whole-body adiposity and muscle adiposity are similar in both diabetes types, visceral abdominal fat is more strongly related to muscle adiposity in type 2 diabetes compared to type 1 diabetes suggesting that insulin resistance may modulate this relationship. In well-controlled type 1 diabetes, greater muscle fat accumulation tended to be related to higher insulin requirement but not with glycemic control, suggesting that minimizing hyperglycemia in these patients may normalize the muscle fat abnormalities found in less well-controlled type 1 diabetes.
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